These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 16275125)

  • 1. Cilostazol in secondary prevention of stroke: impact of the Cilostazol Stroke Prevention Study.
    Matsumoto M
    Atheroscler Suppl; 2005 Dec; 6(4):33-40. PubMed ID: 16275125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiplatelet cilostazol is beneficial in diabetic and/or hypertensive ischemic stroke patients. Subgroup analysis of the cilostazol stroke prevention study.
    Shinohara Y; Gotoh F; Tohgi H; Hirai S; Terashi A; Fukuuchi Y; Otomo E; Itoh E; Matsuda T; Sawada T; Yamaguchi T; Nishimaru K; Ohashi Y
    Cerebrovasc Dis; 2008; 26(1):63-70. PubMed ID: 18511873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefit of cilostazol in patients with high risk of bleeding: subanalysis of cilostazol stroke prevention study 2.
    Uchiyama S; Shinohara Y; Katayama Y; Yamaguchi T; Handa S; Matsuoka K; Ohashi Y; Tanahashi N; Yamamoto H; Genka C; Kitagawa Y; Kusuoka H; Nishimaru K; Tsushima M; Koretsune Y; Sawada T; Hamada C
    Cerebrovasc Dis; 2014; 37(4):296-303. PubMed ID: 24820203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of cilostazol for secondary stroke prevention: an old dog with new tricks?
    Ansara AJ; Shiltz DL; Slavens JB
    Ann Pharmacother; 2012 Mar; 46(3):394-402. PubMed ID: 22353234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protocol for Cilostazol Stroke Prevention Study for Antiplatelet Combination (CSPS.com): a randomized, open-label, parallel-group trial.
    Toyoda K; Uchiyama S; Hoshino H; Kimura K; Origasa H; Naritomi H; Minematsu K; Yamaguchi T;
    Int J Stroke; 2015 Feb; 10(2):253-8. PubMed ID: 25487817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale and design of the PreventIon of CArdiovascular events in iSchemic Stroke patients with high risk of cerebral hemOrrhage (PICASSO) study: A randomized controlled trial.
    Hong KS; Kim BJ; Lee JY; Kwon SU;
    Int J Stroke; 2015 Oct; 10(7):1153-8. PubMed ID: 26044566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy and safety of cilostazol in ischemic stroke patients with peripheral arterial disease (SPAD): protocol of a randomized, double-blind, placebo-controlled multicenter trial.
    Jeng JS; Sun Y; Lee JT; Lin RT; Chen CH; Po HL; Lin HJ; Liu CH; Sun MH; Sun MC; Chern CM; Lien LM; Chiu HC; Hu HH; Chiou HY; Chen ST; Ma H; Hsu CY;
    Int J Stroke; 2015 Jan; 10(1):123-7. PubMed ID: 25394855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Results of the Cilostazol Stroke Prevention Study II (CSPS II): a randomized controlled trial for the comparison of cilostazol and aspirin in stroke patients].
    Uchiyama S
    Rinsho Shinkeigaku; 2010 Nov; 50(11):832-4. PubMed ID: 21921460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of acute medication with cilostazol, an anti-platelet drug, on the outcome of small vessel brain infarction.
    Nakase T; Sasaki M; Suzuki A
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1409-15. PubMed ID: 24513481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale, design and baseline data of a randomized, double-blind, controlled trial comparing two antithrombotic regimens (a fixed-dose combination of extended-release dipyridamole plus ASA with clopidogrel) and telmisartan versus placebo in patients with strokes: the Prevention Regimen for Effectively Avoiding Second Strokes Trial (PRoFESS).
    Diener HC; Sacco R; Yusuf S; ;
    Cerebrovasc Dis; 2007; 23(5-6):368-80. PubMed ID: 17337887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addition of cilostazol reduces biological aspirin resistance in aspirin users with ischaemic stroke: a double-blind randomized clinical trial.
    Lee JH; Cha JK; Lee SJ; Ha SW; Kwon SU
    Eur J Neurol; 2010 Mar; 17(3):434-42. PubMed ID: 19922458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional differences in incidence and management of stroke - is there any difference between Western and Japanese guidelines on antiplatelet therapy?
    Shinohara Y
    Cerebrovasc Dis; 2006; 21 Suppl 1():17-24. PubMed ID: 16479098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of cilostazol versus aspirin for the secondary prevention of stroke.
    Dinicolantonio JJ; Lavie CJ; Fares H; Menezes AR; O'Keefe JH; Bangalore S; Messerli FH
    Am J Cardiol; 2013 Oct; 112(8):1230-4. PubMed ID: 23827403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cilostazol may prevent cardioembolic stroke in patients undergoing antiplatelet therapy.
    Horie N; Kaminogo M; Izumo T; Hayashi K; Tsujino A; Nagata I
    Neurol Res; 2015 Jul; 37(7):619-23. PubMed ID: 25798683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiplatelet cilostazol is effective in the prevention of pneumonia in ischemic stroke patients in the chronic stage.
    Shinohara Y
    Cerebrovasc Dis; 2006; 22(1):57-60. PubMed ID: 16645267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cilostazol research in Asia: can it be applied to European and American patients?
    Kim JS; Kwon SU; Uchiyama S
    Int J Stroke; 2015 Mar; 10 Suppl 1():1-9. PubMed ID: 25736819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enteric-coated aspirin versus other antiplatelet drugs in acute non-cardioembolic ischemic stroke: post-marketing study in Japan.
    Takahashi S; Mizuno O; Sakaguchi T; Yamada T; Inuyama L
    Adv Ther; 2014 Jan; 31(1):118-29. PubMed ID: 24385407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cilostazol in Acute Ischemic Stroke Treatment (CAIST Trial): a randomized double-blind non-inferiority trial.
    Lee YS; Bae HJ; Kang DW; Lee SH; Yu K; Park JM; Cho YJ; Hong KS; Kim DE; Kwon SU; Lee KB; Rha JH; Koo J; Han MG; Lee SJ; Lee JH; Jung SW; Lee BC; Kim JS
    Cerebrovasc Dis; 2011; 32(1):65-71. PubMed ID: 21613787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial.
    Shinohara Y; Katayama Y; Uchiyama S; Yamaguchi T; Handa S; Matsuoka K; Ohashi Y; Tanahashi N; Yamamoto H; Genka C; Kitagawa Y; Kusuoka H; Nishimaru K; Tsushima M; Koretsune Y; Sawada T; Hamada C;
    Lancet Neurol; 2010 Oct; 9(10):959-68. PubMed ID: 20833591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cilostazol for the prevention of acute progressing stroke: a multicenter, randomized controlled trial.
    Shimizu H; Tominaga T; Ogawa A; Kayama T; Mizoi K; Saito K; Terayama Y; Ogasawara K; Mori E;
    J Stroke Cerebrovasc Dis; 2013 May; 22(4):449-56. PubMed ID: 23541423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.